Search
Agency CommentsCAGW Supports a Consistent Cost-Benefit Analysis for the Clean Air Act
The EPA must ensure that the Clean Air Act rules proposed under the Advance Notice of Proposed Rulemaking must provide consistent and high quality cost-benefit analyses for significant rules.
Agency CommentsCoalition Urges CMS to Oppose a Significant Regulatory Expansion of the Medicaid Drug Rebate Program
Coalitions urges CMS Admin to oppose regulatory expansion of the Medicaid Drug Rebate Program.
Agency CommentsCAGW urges White House to Withdraw Proposed EOs regarding Foreign Reference Drug Pricing
CAGW asks the White House Chief of Staff to withdraw any proposed Executive Orders regarding foreign drug pricing.
Agency CommentsCAGW Comments to the FERC on Net Metering
CAGW files comments in favor of New England Ratepayers Association's petition concerning wholesale energy sales.
Agency CommentsCAGW Comments to Philippine FDA on Vapor Product Regulation
CAGW expresses its disappointment over the Philippine Food and Drug Administration’s draft guidelines, “Regulation of Vapor Products and Heated Tobacco Products.”
Agency CommentsCAGW Files Reply Comments on the RIF Order Remand
CAGW files reply comments on the Restoring Internet Freedom Order Remand. Issues include Lifeline/Link Up; pole attachments; and, public safety communications.
Agency CommentsCAGW Files Reply Comments with the FCC in the 5.9 GHz Proceeding
CAGW has long maintained that public resources like the 5.9 GHz band should be maximized to their fullest potential.
Agency CommentsCCAGW Leads Coalition In Supports FCC's Proposed TVWS Rule
The proposed TVWS rule is a leap forward for those whose lives will be improved by this technology, and the coalition urges its adoption.
Agency CommentsCoalition Submits Comments to CEQ on Proposed Updated NEPA Regulations
CCAGW joins coalition with 10 other free market groups in support of the CEQ's Propsed Updated Regulations for implementing NEPA.
Agency CommentsCAGW Submits Comments to FDA on Drug Importation Proposed Rule
Comments to the Food and Drug Administration on Proposed Rule for Importing Drugs from Canada
Agency CommentsCAGW Submits Comments to FCC on 5.850-5.925 GHz Band Usage
CAGW offers comments supporting the FCC's NPRM to expand and enhance the use of the 5.850 – 5.925 GHz spectrum band.
Agency CommentsComment to FDA on Draft Guidance for Importation of Certain Drugs
Citizens Against Government Waste's Comment on Draft Guidance: Importation of Certain Food and Drug Administration-Approved Human Prescription Drugs, Including Biological Products
